ESSA Pharma Price Prediction
| EPIXDelisted Stock | USD 0.20 0.00 0.00% |
Momentum 9
Sell Peaked
Oversold | Overbought |
Using ESSA Pharma hype-based prediction, you can estimate the value of ESSA Pharma from the perspective of ESSA Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in ESSA Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying ESSA because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ESSA Pharma after-hype prediction price | USD 0.2 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
ESSA |
ESSA Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of ESSA Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ESSA Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ESSA Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ESSA Pharma Estimiated After-Hype Price Volatility
In the context of predicting ESSA Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ESSA Pharma's historical news coverage. ESSA Pharma's after-hype downside and upside margins for the prediction period are 0.01 and 4.19, respectively. We have considered ESSA Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ESSA Pharma is out of control at this time. Analysis and calculation of next after-hype price of ESSA Pharma is based on 3 months time horizon.
ESSA Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as ESSA Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ESSA Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ESSA Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.06 | 3.99 | 0.00 | 0.01 | 0 Events / Month | 2 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.20 | 0.20 | 0.00 |
|
ESSA Pharma Hype Timeline
ESSA Pharma is currently traded for 0.20. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. ESSA is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.06%. %. The volatility of related hype on ESSA Pharma is about 1693.87%, with the expected price after the next announcement by competition of 0.19. About 74.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.09. Some equities with similar Price to Book (P/B) outperform the market in the long run. ESSA Pharma recorded a loss per share of 0.57. The entity last dividend was issued on the 25th of August 2025. The firm had 1:20 split on the 25th of April 2018. Given the investment horizon of 90 days the next forecasted press release will be in a few days. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.ESSA Pharma Related Hype Analysis
Having access to credible news sources related to ESSA Pharma's direct competition is more important than ever and may enhance your ability to predict ESSA Pharma's future price movements. Getting to know how ESSA Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ESSA Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| APGN | Apexigen | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TNFA | TNFA Old | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CSCI | COSCIENS Biopharma | (0.11) | 6 per month | 9.36 | 0.01 | 6.37 | (10.61) | 94.83 | |
| CRVO | CervoMed | (0.11) | 3 per month | 3.58 | (0.01) | 6.49 | (6.17) | 17.75 | |
| CHRO | CHRO Old | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SCPX | Scorpius Holdings | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BIOR | Biora Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| KRRO | Frequency Therapeutics | (1.90) | 8 per month | 0.00 | (0.12) | 12.19 | (10.00) | 91.55 | |
| TSBX | Turnstone Biologics Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
ESSA Pharma Additional Predictive Modules
Most predictive techniques to examine ESSA price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ESSA using various technical indicators. When you analyze ESSA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About ESSA Pharma Predictive Indicators
The successful prediction of ESSA Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ESSA Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ESSA Pharma based on analysis of ESSA Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ESSA Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ESSA Pharma's related companies.
Story Coverage note for ESSA Pharma
The number of cover stories for ESSA Pharma depends on current market conditions and ESSA Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ESSA Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ESSA Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
ESSA Pharma Short Properties
ESSA Pharma's future price predictability will typically decrease when ESSA Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ESSA Pharma often depends not only on the future outlook of the potential ESSA Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ESSA Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 44.3 M | |
| Cash And Short Term Investments | 126.8 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in ESSA Stock
If you are still planning to invest in ESSA Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ESSA Pharma's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |